Petterson, J.; Mustafa, D.; Bandaru, S.; Eklund, E.Ä.; Hallqvist, A.; Sayin, V.I.; Gagné, A.; Fagman, H.; Akyürek, L.M.
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas. Int. J. Mol. Sci. 2024, 25, 2959.
https://doi.org/10.3390/ijms25052959
AMA Style
Petterson J, Mustafa D, Bandaru S, Eklund EÄ, Hallqvist A, Sayin VI, Gagné A, Fagman H, Akyürek LM.
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas. International Journal of Molecular Sciences. 2024; 25(5):2959.
https://doi.org/10.3390/ijms25052959
Chicago/Turabian Style
Petterson, Jennie, Dyar Mustafa, Sashidar Bandaru, Ella Äng Eklund, Andreas Hallqvist, Volkan I. Sayin, Andréanne Gagné, Henrik Fagman, and Levent M. Akyürek.
2024. "Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas" International Journal of Molecular Sciences 25, no. 5: 2959.
https://doi.org/10.3390/ijms25052959
APA Style
Petterson, J., Mustafa, D., Bandaru, S., Eklund, E. Ä., Hallqvist, A., Sayin, V. I., Gagné, A., Fagman, H., & Akyürek, L. M.
(2024). Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas. International Journal of Molecular Sciences, 25(5), 2959.
https://doi.org/10.3390/ijms25052959